Although sodium valproate (VPA)-induced hepatic encephalopathy is a well-recognized entity. VPA can occasionally produce encephalopathy secondary to hyperammonemia in the presence of normal hepatic function. namely valproate-induced non-hepatic hyperammonemic encephalopathy (VNHE). Known risk factors include therapy with multiple antiepileptic drugs. https://wholesfoodsboxs.shop/product-category/minerals/